EKF Diagnostics (LON:EKF – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported GBX 1.38 ($0.02) earnings per share (EPS) for the quarter, Digital Look Earnings reports. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%.
EKF Diagnostics Price Performance
Shares of LON EKF opened at GBX 22 ($0.28) on Tuesday. The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34. EKF Diagnostics has a fifty-two week low of GBX 18.40 ($0.24) and a fifty-two week high of GBX 33.80 ($0.44). The business has a 50 day moving average price of GBX 23.35 and a two-hundred day moving average price of GBX 25.91. The firm has a market cap of £97.78 million, a PE ratio of 20.47 and a beta of 0.57.
About EKF Diagnostics
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
See Also
- Five stocks we like better than EKF Diagnostics
- The Most Important Warren Buffett Stock for Investors: His Own
- Top 3 Insider Stock Buys in March—Are They Still Good in April?
- Upcoming IPO Stock Lockup Period, Explained
- Pharma Frenzy: Volatility Ignites Biotech Sector
- How to find penny stocks to invest and trade
- Warren Buffett Thinks This Country Could Be the Next Big Bet
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
